Patents by Inventor Qiang Fan

Qiang Fan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160253447
    Abstract: A method for facilitating semiconductor device manufacturing may include the following steps: receiving a custom design data set, which complies with a first element-identification scheme; generating a compatible design data set using the custom design data set, wherein data elements in the compatible design data set correspond to data elements in the custom design data set, and wherein the compatible design data set is compatible with a dummy-pattern-data generation module; generating a first dummy-pattern data set using the dummy-pattern-data generation module and the compatible design data set; and generating a second dummy-pattern data set using the first dummy-pattern data set, wherein data elements in the second dummy-pattern data set correspond to data elements in the first dummy-pattern data set, and wherein the second dummy-pattern data set complies with the first element-identification scheme.
    Type: Application
    Filed: February 3, 2016
    Publication date: September 1, 2016
    Inventor: Qiang FAN
  • Patent number: 9381194
    Abstract: The invention relates to methods of enhancing normal melanocortin-4 receptor (MC4R) activity, and to enhancing activity of an MC4R having a mutation which affects protein folding and/or processing of the MC4R. The invention provides a method of treating an individual having a condition in which increased activity of an MC4R at the cell surface would be beneficial, for example in obesity, by administering an effective amount of a pharmacological chaperone for the MC4R. The invention provides MC4R pharmacological chaperones which enhance the activity of MC4R. The invention further provides a method of screening to identify pharmacological chaperones which enhance folding of an MC4R in the endoplasmic reticulum (ER), in order to enhance the activity of the MC4R at the cell surface.
    Type: Grant
    Filed: August 3, 2009
    Date of Patent: July 5, 2016
    Assignee: Amicus Therapeutics, Inc.
    Inventors: Jian-Qiang Fan, Kenneth Valenzano, Gary Lee, Michel Bouvier, Patricia René
  • Patent number: 9334395
    Abstract: Compatibilized blends comprising a first phase comprising a thermoplastic olefin polymer and a second phase comprising a crosslinked, thermoplastic polyurethane are provided. The first phase is a continuous phase and the second phase can be co-5 continuous with the first phase, or dispersed as a non-continuous phase in the first phase. The blends further include a phenolic resole resin which at least partially crosslinks the thermoplastic polyurethane and acts as a compatibilizer for the olefin polymer and the thermoplastic polyurethane.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: May 10, 2016
    Assignee: Dow Global Technologies LLC
    Inventors: Yabin Sun, Xiang Yang Tai, Li Qiang Fan
  • Patent number: 9321912
    Abstract: Disclosed is a halogen-free, flame retardant thermoplastic resin composition based on polypropylene and one or more thermoplastic elastomers with an organic nitrogen- and/or phosphorus-based intumescent flame retardant comprising a piperazine component. The composition is processed easily to make a wire and cable sheath exhibiting a balance of high flame retardancy, good flexibility, high wet electrical resistance and excellent heat deformation properties, and which passes the VW-I flame retardancy test, the UL1581 heat deformation test at 150° C. and the wet electrical resistance test, and also exhibits good tensile and flexibility properties. Also disclosed is a wire and cable sheath made from the composition.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: April 26, 2016
    Assignee: Dow Global Technologies LLC
    Inventors: Xiang Yang Tai, Yabin Sun, Yurong Cao, Li Qiang Fan, Lin Fu, Geoffrey D. Brown, Manish Mundra
  • Patent number: 9295670
    Abstract: The present invention relates to methods for treating obstructive sleep apnea (OSA), alleviating a negative OSA symptom, reducing snoring, or improving quality of life in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising pyridostigmine before sleep. Also provided are related medicaments as well as methods for preparing the medicaments.
    Type: Grant
    Filed: May 5, 2014
    Date of Patent: March 29, 2016
    Assignee: PFANTASTIC MEDICAL RESEARCH INSTITUTE, LLC
    Inventor: Jian-Qiang Fan
  • Patent number: 9265780
    Abstract: A method of enhancing the activity of lysosomal ?-Galactosidase A (?-Gal A) in mammalian cells and for treatment of Fabry disease by administration of 1-deoxy-galactonojirimycin and related compounds.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: February 23, 2016
    Assignee: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventors: Jian-Qiang Fan, Satoshi Ishii
  • Publication number: 20150370957
    Abstract: A layout design method is disclosed. The layout design method includes: (a) providing an original layout file; (b) performing a redundant via (RV) filling on the original layout file so as to generate a second layout file; (c) merging the second layout file with the original layout file to generate a third layout file; (d) performing a design rule check (DRC) verification on the third layout file by directly invoking a DRC code in a Process Design Kit (PDK); (e) generating, based on a result of the DRC verification, a fourth layout file including DRC errors; (f) performing a layout operation to remove DRC errors from the second layout file using the fourth layout file, so as to generate a fifth layout file; and (g) merging the fifth layout file with the original layout file to generate a sixth layout file.
    Type: Application
    Filed: June 10, 2015
    Publication date: December 24, 2015
    Inventors: Qiang FAN, Xue LI
  • Patent number: 9189590
    Abstract: A method for examining quality of a dummy pattern insertion program may be implemented using a device that includes hardware. The method may include using the dummy pattern insertion program to generate a dummy-based circuit layout, a first dummy-inserted circuit layout, and a second dummy-inserted circuit layout. The method may further include determining whether the dummy-based circuit layout complies with a set of circuit layout design rules. The method may further include checking whether the first dummy-inserted circuit layout complies with at least one of a set of dummy pattern check rules and a set of pattern density rules. The method may further include examining whether the second dummy-inserted circuit layout complies with at least one of the set of circuit layout design rules, the set of dummy pattern check rules, and the set of pattern density rules.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: November 17, 2015
    Assignee: SEMICONDUCTOR MANUFACTURING INTERNATIONAL (SHANGHAI) CORPORATION
    Inventor: Qiang Fan
  • Publication number: 20150299506
    Abstract: A composition is disclosed that includes fluorinated polymer and a non-fluorinated polymer. The fluorinated polymer includes first divalent units independently represented by formula and second divalent unit independently comprising a pendent cationic, anionic, amphoteric, or amine-oxide group or a pendent poly(alkyleneoxy) segment. The non-fluorinated polymer is R2O-(EO)p—(R3O)q-(EO)p—R2 or R2O—(R3O)q-(EO)p—(R3O)q—R2. A method of making the composition and methods of reducing the surface tension of a liquid and a method of treating a hydrocarbon-bearing formation are also disclosed.
    Type: Application
    Filed: November 19, 2013
    Publication date: October 22, 2015
    Inventors: Wayne Wei-Qiang Fan, Dong-Wei Zhu, Rudolf J. Dams, Yong K. Wu
  • Publication number: 20150258129
    Abstract: Method for enhancing in a mammalian cell the activity of an enzyme associated with Gaucher Disease by administering a competitive inhibitor of glucocerebrosidase in an amount effective to enhance the activity of the enzyme. Preferred compounds for use in the method are imino sugars and related compounds. In particular, C8-12-alkyl derivatives of N-alkyl-deoxymojirimycin, isofagomine compounds, and calystegine compounds are effective to enhance glucocerebrosidase activity.
    Type: Application
    Filed: August 18, 2014
    Publication date: September 17, 2015
    Inventors: Jian-Qiang Fan, Satoshi Ishii, Naoki Asano
  • Publication number: 20150186593
    Abstract: A method for examining quality of a dummy pattern insertion program may be implemented using a device that includes hardware. The method may include using the dummy pattern insertion program to generate a dummy-based circuit layout, a first dummy-inserted circuit layout, and a second dummy-inserted circuit layout. The method may further include determining whether the dummy-based circuit layout complies with a set of circuit layout design rules. The method may further include checking whether the first dummy-inserted circuit layout complies with at least one of a set of dummy pattern check rules and a set of pattern density rules. The method may further include examining whether the second dummy-inserted circuit layout complies with at least one of the set of circuit layout design rules, the set of dummy pattern check rules, and the set of pattern density rules.
    Type: Application
    Filed: July 29, 2014
    Publication date: July 2, 2015
    Inventor: Qiang FAN
  • Patent number: 8973826
    Abstract: A method of imaging a target object with an imaging reader. The method includes the following: (1) detecting light from the target object through a lens arrangement with an image sensor to generate light-field data; (2) generating a stream of image data including image data representing an expected in-focus image of the target object, and (3) processing the expected in-focus image of the target object to decode a barcode on the target object. The image sensor includes an array of photosensitive elements and an array of microlenses that overlays the array of photosensitive elements located at a focus plane of the microlens.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: March 10, 2015
    Inventors: Duanfeng He, Vladimir Gurevich, David P. Goren, Nong-Qiang Fan
  • Patent number: 8865808
    Abstract: Halogen-free TPU compositions comprise in weight percent based on the weight of the composition: A. 1 to 99% thermoplastic polyurethane (TPU), B. 1 to 50% tris(2-butoxyethyl)phosphate (TBEP), C. 1 to 70% metal hydrate, and D. 1 to 70% organic phosphate ester other than tris(2-butoxyethyl)phosphate. These compositions exhibit better smoke suppression as compared with conventional organic phosphate flame retardant TPU compositions such as those based on resorcinol bis(diphenyl phosphate) (RDP) and bisphenol-A bis(diphenyl phosphate) (BPADP) in the absence of TBEP.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: October 21, 2014
    Assignee: Dow Global Technologies LLC
    Inventors: Xiangyang Tai, Given Jing Chen, Yurong Cao, Li Qiang Fan
  • Patent number: 8841322
    Abstract: Method for enhancing in a mammalian cell the activity of an enzyme associated with Gaucher Disease by administering a competitive inhibitor of glucocerebrosidase in an amount effective to enhance the activity of the enzyme. Preferred compounds for use in the method are imino sugars and related compounds. In particular, C8-12-alkyl derivatives of N-alkyl-deoxynojirimycin, isofagomine compounds, and calystegine compounds are effective to enhance glucocerebrosidase activity.
    Type: Grant
    Filed: April 22, 2013
    Date of Patent: September 23, 2014
    Assignee: Mount Sinai School of Medicine of New York University
    Inventors: Jian-Qiang Fan, Satoshi Ishii, Naoki Asano
  • Publication number: 20140238412
    Abstract: The present invention relates to methods for treating obstructive sleep apnea (OSA), alleviating a negative OSA symptom, reducing snoring, or improving quality of life in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising pyridostigmine before sleep. Also provided are related medicaments as well as methods for preparing the medicaments.
    Type: Application
    Filed: May 5, 2014
    Publication date: August 28, 2014
    Applicant: Pfantastic Medical Research Institute, LLC
    Inventor: Jian-Qiang FAN
  • Publication number: 20140206718
    Abstract: A method of enhancing the activity of lysosomal ?-Galactosidase A (?-Gal A) in mammalian cells and for treatment of Fabry disease by administration of 1-deoxy-galactonojirimycin and related compounds.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 24, 2014
    Applicant: Mount Sinai School of Medicine of New York University
    Inventors: Jian-Qiang Fan, Satoshi Ishii
  • Patent number: 8753327
    Abstract: The present invention relates to methods for treating obstructive sleep apnea (OSA), alleviating a negative OSA symptom, reducing snoring, or improving quality of life in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising pyridostigmine before sleep. Also provided are related medicaments as well as methods for preparing the medicaments.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: June 17, 2014
    Assignee: Pfantastic Medical Research Institute, LLC
    Inventor: Jian-Qiang Fan
  • Publication number: 20140108491
    Abstract: The present invention provides a method and an apparatus for controlling a terminal, and a terminal. The method includes: receiving a terminal identity sent by a terminal; acquiring, according to the terminal identity, time control information that corresponds to an application identity of an application on the terminal; and sending the time control information to the terminal, so that the terminal controls, according to the time control information, use time of the application that corresponds to the application identity.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: HUAWEI DEVICE CO., LTD.
    Inventors: Cunzhi Fan, Qiang Fan, Ling Zhang, Feilong Zhang
  • Publication number: 20140097252
    Abstract: A method of imaging a target object with an imaging reader. The method includes the following: (1) detecting light from the target object through a lens arrangement with an image sensor to generate light-field data; (2) generating a stream of image data including image data representing an expected in-focus image of the target object, and (3) processing the expected in-focus image of the target object to decode a barcode on the target object. The image sensor includes an array of photosensitive elements and an array of microlenses that overlays the array of photosensitive elements located at a focus plane of the microlens.
    Type: Application
    Filed: December 9, 2013
    Publication date: April 10, 2014
    Applicant: SYMBOL TECHNOLOGIES, INC.
    Inventors: Duanfeng He, Vladimir Gurevich, David P. Goren, Nong-Qiang Fan
  • Patent number: 8633221
    Abstract: A method of enhancing the activity of lysosomal ?-Galactosidase A (?-Gal A) in mammalian cells and for treatment of Fabry disease by administration of 1-deoxy-galactonojirimycin and related compounds.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: January 21, 2014
    Assignee: Mount Sinai School of Medicine of New York University
    Inventors: Jian-Qiang Fan, Satoshi Ishii